Status:
COMPLETED
Human Chorionic Gonadotropin (hCG) Test: A Novel Method to Evaluate the Ovarian Reserve
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Infertility
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
In an era of delayed fertility plans, there is an increasing need for a reliable method to predict ovarian reserve and responsiveness. The current tests include serum FSH, Inhibin B, Mullerian inhibit...
Detailed Description
20 women \>40 years old and 20 women \<35 years old, attended to our IVF unit were included in the study. Another 20 other young women (\<35 years) with poor response in previous IVF cycles will be pa...
Eligibility Criteria
Inclusion
- All women on IVF cycle
Exclusion
- Any allergy to injection of human chorionic gonadotropin before
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00646568
Start Date
June 1 2008
End Date
January 1 2010
Last Update
June 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical center
Jerusalem, Israel, 12000